Tums Tablet
Pricing Report NDC 0135-0071-27

Latest NADAC: $0.02742 per EA · Effective Apr 22, 2020 · Est. package price $4.11 (150 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Tums (NDC 0135-0071-27) is $0.02742 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 22, 2020.

As a a human over the counter drug provided by Haleon Us Holdings Llc, this medication is distributed in a 150 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.02742
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 22, 2020
Billable Units
150 EA
Estimated Package Price
$4.11
Data Status
As of Jul 01, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0135-0071-27
Description
150 TABLET in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.01387 (Effective: Jun 17, 2020)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.02600 to $0.03542 per EA. Over this 6 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0260 - $0.0354
Market Volatility
36.23% Variance
Latest Trend
12.03%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 22, 2020 $0.02742 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2020 $0.02742 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 22, 2020 $0.02742 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Apr 22, 2020 $0.02742 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 18, 2020 $0.03117 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 18, 2020 $0.03117 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2020 $0.02693 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2020 $0.02693 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jan 22, 2020 $0.02693 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2020 $0.02693 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 18, 2019 $0.02753 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 18, 2019 $0.02753 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026